This market environment is not like others that came before it.

Remember people used to complain that only 5 stocks were driving the market?

Now they complain that those 5 stocks aren't working.

But many others are.

And that's the point.

With new environments comes new leadership. We've seen this happen over many decades.

And those 5 stocks that everyone used to complain were driving the market, have now been laggards for quite some time.

I think people just like to complain.

But if you're like us, and would rather look for opportunities to profit instead of just bitching all the time, then it's important to look underneath the surface.

A great way to visualize the broader leadership vs just a few names is in the equally-weighted chart of the S&P500. This eliminates those mega-caps from dominating the indexes.

Here's how that looks compared to the market-cap weighted version:

From the Desk of Steve Strazza @Sstrazza and Alfonso Depablos @AlfCharts

A few days ago, we wrote about two large-cap secular leaders from our Inside Scoop list.

We love betting on long-term outperformers.

We discussed them on Wednesday's live strategy session as well.

We also outlined some new long ideas in stocks that are showing relative strength over shorter timeframes.

Let's talk about these names a little more now.

From the desk of Steve Strazza @Sstrazza and Alfonso Depablos @AlfCharts

Our Hall of Famers list is composed of the 150 largest US-based stocks.

These stocks range from the mega-cap growth behemoths like Apple and Microsoft – with market caps in excess of $2T – to some of the new-age large-cap disruptors such as Moderna, Square, and Snap.

It has all the big names and more.

It doesn’t include ADRs or any stock not domiciled in the US. But don’t worry; we developed a separate universe for that. You can click here to check it out.

The Hall of Famers is simple.

We take our list of 150 names and then apply our technical filters so the strongest stocks with the most momentum rise to the top.

Let’s dive right in and check out what these big boys are up to.

Here’s this week’s list:

From the Desk of Steve Strazza @Sstrazza

Equity markets around the globe are getting rocked as we close out another rough week.

And then there's China, which is green on the day.

This isn't just a one-day thing. In fact, it's quite the opposite. China has been showing impressive relative strength since bottoming in late October.

Today is just a microcosm of what that leadership has looked like.

It's had our attention for a while already, which is why we're about to discuss the structural outlook for Chinese stocks and outline some long ideas in the strongest names.

Here's the performance of a basket of international equity ETFs since markets bottomed and ripped higher on Oct. 13:

From the Desk of Kimmy Sokoloff

Today $SPY filled its gap from the Nov. 10 CPI print.

We're currently below the major moving averages.

The largest insider buy on today’s list comes in a Form 4 filing by Bryant R. Riley, chairman and CEO of B. Riley Financial $RILY.

Riley reported a purchase of $2.5 million worth of RILY stock.

From the Desk of Kimmy Sokoloff

Another gap lower for the indices this morning. I'll be watching to see if the $SPX can hold 3,861 or so.

I was looking for a gap down. Now we'll see if we can get a bounce.

With the major indexes below overhead supply, you're seeing the choppy action.

There are stocks continuing to do very well, like Homebuilders for example. And there are some stocks really struggling, like U.S. Banks.

But in the aggregate, at the index level, you're seeing the grind.

From the Desk of Kimmy Sokoloff

The market opened lower and continued on that path all day.

It was a tough day, and I tried to manage risk.

The $SPX hit some support at 3,887. The next level down is 3,867.

Regardless of whether the majority of stocks in the market are going up or down, there seems to always be a group that just wants to keep on falling in price.

They can't help themselves.

Investors just hate them.

And with that hatred, of course, comes opportunity.

Here's this week's shit list:

From the Desk of Steve Strazza @Sstrazza and Alfonso Depablos @AlfCharts

We're still picking our spots selectively when it comes to long ideas on our Inside Scoop list.

However, every now and then, some secular leaders pop up on our scan, offering us nice entries and favorable risk-reward ratios.

We're always looking for ways to gain exposure to these outperformers.

Today, we have two industry bellwethers and household names that recently broke out to new highs relative to the broader market.

Let's take a look at these leaders now.

The largest insider buy on today’s list comes in a Form 4 filing by the early stage life sciences investment firm Atlas Venture.

The venture capital fund now owns a total stake in Dyne Therapeutics $DYN of more than 17%.